Hemorrhoids (Grade II-III, Symptomatic)
Investigational use for symptomatic relief of grade II-III internal/external hemorrhoidal disease; does not address anatomic prolapse.
Patient Summary
- Is this FDA-cleared for this use?
- Not FDA-cleared for hemorrhoids. FDA cleared medicinal leeches only for venous congestion in microsurgical reconstruction (K040187, 2004). Use for hemorrhoidal symptoms is investigational.
- What evidence exists?
- Tier C (investigational). Only small uncontrolled studies were identified (about 12 to 37 patients each, mostly in thrombosed or prolapsed hemorrhoids), reporting less pain after leech application; in one of them 2 of 12 patients had uncontrolled bleeding. There are no randomized controlled trials. Critical safety boundary: leeches must NEVER be placed inside the anal canal. Definitive treatments (rubber-band ligation, sclerotherapy, hemorrhoidectomy, fiber/hydration) remain standard of care; grade IV hemorrhoids require surgical referral.
- Main risks
- Bleeding from bite sites for 6 to 24 hours after detachment (anatomically near rectal bleeding sources — distinguish from hemorrhoidal bleeding)
- Bruising and tenderness in the perianal area for 5 to 10 days
- Itching at bite sites
- Local skin infection or, rarely, Aeromonas infection (heightened concern given perianal location)
- Allergic reaction to leech saliva (uncommon)
- Worsening pain or anal discomfort for 1 to 3 days after the session
- Small bite marks that usually fade over weeks to months (rarely a pale spot stays longer)
- Catastrophic bleeding if leech is mistakenly placed intra-anally (NEVER do this)
- Delay of surgical excision (the fastest pain-relief option within 72 hours)
- Failure to address strangulated or gangrenous hemorrhoids that require emergent surgery
- Who should not consider this
- Patients on blood thinners (anticoagulants such as warfarin, DOACs or heparin)
- Patients with hemophilia or other bleeding disorders
- Patients with anemia
- Patients with grade IV (irreducible) hemorrhoids — need surgical referral
- Patients with active perianal abscess or fissure
- Patients with inflammatory bowel disease and active proctitis
- Patients with HIV, diabetes, or immunosuppression (higher infection risk)
- Patients with strangulated or gangrenous thrombosed hemorrhoid (emergent surgical indication)
- Patients with active perianal abscess or fistula
- Patients with active genital or perianal infection
- Pregnant patients (leech therapy is not done during pregnancy)
- What to ask your clinician
- Have I been evaluated by a colorectal surgeon, and is my hemorrhoid grade appropriate for this?
- Have I been worked up for other causes of rectal bleeding (colonoscopy when indicated)?
- What evidence supports leech therapy for hemorrhoids specifically?
- What is the practitioner's experience and Aeromonas-prevention plan in this region?
- How will leeches be kept extra-anal?
- What is the realistic chance of benefit, and for how long?
- What is the cost, and what does it commit me to?
- Has my external thrombosed hemorrhoid been examined to rule out strangulation, gangrene, or abscess?
- Am I within the 72-hour window where surgical excision provides the fastest relief?
- When to seek urgent care
- Heavy or persistent rectal bleeding, especially soaking through pads or causing dizziness
- Severe perianal pain, spreading redness, or pus (perianal abscess or cellulitis)
- Fever above 38.0 C / 100.4 F or chills
- Bleeding from a bite site lasting more than 24 to 48 hours
- Hives, throat tightness, or breathing difficulty
- Inability to urinate or defecate after the session
- Skin discoloration, blackening, or necrosis of the hemorrhoid
What this does NOT mean
- This is not FDA-cleared for hemorrhoids.
- The small uncontrolled studies identified do not provide evidence of efficacy or long-term benefit in the general population.
- Symptomatic relief does NOT correct hemorrhoidal anatomy — recurrence is expected.
- Leech therapy is not a substitute for colorectal evaluation, especially with bleeding.
- Mechanism rationale does NOT establish clinical efficacy versus standard treatments.
- Leech therapy is not a substitute for surgical excision in the 72-hour window or emergent surgery for strangulated / gangrenous hemorrhoids.
Safety cross-references
Clinical Profile
- Category
- Gastrointestinal
- ICD-10
- K64.0, K64.1, K64.2, K64.8
- Safety tier
- Medium
Evidence Summary
No randomized or controlled trial of leech therapy for hemorrhoids was identified. The clinical evidence consists of small uncontrolled series, mostly from Ayurvedic and Unani centres: Bhagat 2012 (Ayu; n=12 thrombosed piles, pain score 1.2 to 0.1, two patients with uncontrolled bleeding), Khanna 2017 (Ayushdhara; n=30 thrombosed piles), Mobeen 2021 (J Coloproctol; n=20 grade 3-4 hemorrhoids, pain improved 55% by clinician rating, bleeding 10% and not significant) and Udaya Kiran 2023 (Int J Ayurvedic Med; n=30 prolapsed piles), plus a Soviet-era report of 37 patients with thrombosed nodes (Gryaznova 1970, cited in Baskova and Isakhanyan 2004). The four recent series report a single treated group. The proposed mechanism is local decongestion and anti-inflammatory effects of salivary peptides. Critical safety note: if leeches are used at all, they must NEVER be placed inside the anal canal, where there is significant bleeding and abscess risk. Grade IV (irreducible prolapse) requires surgical referral. Given the small and uncontrolled evidence, leech therapy has no established role and should be regarded, at most, as an unproven interim symptomatic measure.
What the books describe
Below is a summary of what books on hirudotherapy say about this condition. These are the authors’ observations, not a proven effect and not a promise of results. Hirudotherapy has contraindications; the decision is made by a physician.
- Baskova and Isakhanyan include external and internal hemorrhoids in a list of diseases for which, as they write with reference to published reports, treatment with leeches is recommended; they do not single out acute external thrombosed hemorrhoids as a separate condition[B1].
- Of the specific observations on hemorrhoids the book gives one — a brief report by V. V. Gryaznova (1970): among 37 patients, as stated there, 36 showed improvement, and the duration of treatment was shortened from 10–12 days to 4–5[B1].
- What exactly was called improvement, how long the patients were followed and what the treatment times were compared with is not clear from the text; no comparison group is mentioned in the text; the sentence on the simplicity and effectiveness of the method in thrombophlebitis of the hemorrhoidal veins in outpatient settings is stated impersonally in the text, and who draws this conclusion is not said[B1].
- As the authors explain, extracting blood through prolonged bleeding from the small wound helps reduce local inflammatory swelling and venous stasis, and the components of the leech's saliva have a local anti-inflammatory effect; they name hemorrhoids among the surgical diseases in which, in their view, these effects predetermine the successful use of hirudotherapy[B1].
- Michalsen et al. do not describe hemorrhoids, including acute thrombosed ones, among the indications for hirudotherapy: in the historical overview (Chapter 2, Wittke-Michalsen) the hemorrhoidal veins are merely named among the places where, in the view of eighteenth-century physicians, leeches could be applied but cupping could not be done[B3].
- Among the contraindications Baskova and Isakhanyan name hemophilia, hemorrhagic diatheses, anemias, low blood pressure and acute vascular insufficiency, emaciation, concurrent use of anticoagulants (especially long-term and daily), concurrent use of alcohol and individual intolerance, and at high body temperature they advise refraining from leeches[B1].
- Flecken and Michalsen, in the chapter on contraindications, call hemophilia and the use of anticoagulants an absolute contraindication, and in anemia, according to them, treatment involving blood removal is generally contraindicated; aspirin and clopidogrel are not in themselves a contraindication, but at the first session they advise reducing the number of leeches and asking the patient about a tendency to bleed[B3].
Treatment specifics
How many leeches, where they are placed, how long a session lasts, and whether to repeat are clinical decisions made by a qualified provider under institutional protocol — not something to self-administer. Discuss the specifics with a clinician experienced in medicinal leech therapy. (Clinicians: where the society's reference books describe a protocol, it is shown in the clinician view — switch the audience selector in the top bar to “Clinician”.)
Contraindications
- Hemophilia or another bleeding disorder
- Taking anticoagulants (blood thinners such as warfarin or heparin)
- Anemia or suppressed blood formation
- Low blood pressure, shock, collapse or fainting
- Severe wasting (cachexia)
- Intolerance of leeches or a history of severe allergic reactions
- Pregnancy
- Stomach or duodenal ulcer, erosive gastritis
- Acute infectious disease or high fever
- Severe unstable illness, markedly weakened immunity (for example during chemotherapy) or HIV infection
- Drinking alcohol at the time of treatment
- No consent from the patient
- Grade IV (irreducible) hemorrhoids — surgical referral
- Active perianal abscess or fissure
- Inflammatory bowel disease with active proctitis
- Strangulated or gangrenous thrombosed hemorrhoid (emergent surgical)
- Active perianal abscess or fistula
Related Conditions
Chronic Anal Fissure (>8 Weeks)
Investigational idea for chronic anal fissure refractory to medical therapy; no clinical study identified; sphincterotomy remains the gold standard.
Non-Alcoholic Fatty Liver Disease (Investigational Adjunct)
Investigational adjunct in NAFLD/MASLD; no human clinical study identified; weight loss, dietary modification, and resmetirom remain primary.
Hepatic Portal Congestion (Non-Cirrhotic, Investigational)
Highly investigational adjunct for non-cirrhotic hepatic congestion; uncontrolled Russian series only; cirrhosis and portal hypertension are absolute exclusions.
Chronic Pancreatitis (Investigational Pain Adjunct)
Highly investigational adjunct for chronic pancreatitis pain refractory to conventional therapy; no clinical study identified; pancreatic enzyme replacement and pain medicine remain primary.
References
- [B1]
Баскова И.П., Исаханян Г.С. Гирудотерапия. Наука и практика [Hirudotherapy: Science and Practice]
Monograph in Russian, 506 pp., ISBN 5-89527-058-1. Chapter 15: sensation at the bite, length of the session; secretion kininases and pain.
- [B3]
Michalsen A., Roth M., Dobos G. Medicinal Leech Therapy
ISBN 978-3-13-143581-1 / 978-1-58890-563-5. Chapter 9, p. 107: perceptions of the bite — a local dragging pain lasting around one to five minutes.
The information on this page is based on the hirudotherapy books listed under References and reflects the experience their authors describe. Sensations and results differ from person to person. This information is not medical advice, a diagnosis or a prescription, and it does not replace an examination by a physician. Do not stop or change any prescribed treatment without your physician. Hirudotherapy has contraindications.